These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8695717

  • 21. Macrophage-stimulating protein (MSP) and its receptor, RON, stimulate human osteoclast activity but not proliferation: effect of MSP distinct from that of hepatocyte growth factor.
    Kurihara N, Tatsumi J, Arai F, Iwama A, Suda T.
    Exp Hematol; 1998 Oct; 26(11):1080-5. PubMed ID: 9766449
    [Abstract] [Full Text] [Related]

  • 22. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
    Ratajczak MZ, Ratajczak J, Machalinski B, Majka M, Marlicz W, Carter A, Pietrzkowski Z, Gewirtz AM.
    Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
    [Abstract] [Full Text] [Related]

  • 23. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells.
    McKenna HJ, de Vries P, Brasel K, Lyman SD, Williams DE.
    Blood; 1995 Nov 01; 86(9):3413-20. PubMed ID: 7579445
    [Abstract] [Full Text] [Related]

  • 24. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 01; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 25. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Sep 01; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive G alpha i proteins.
    Broxmeyer HE, Youn BS, Kim C, Hangoc G, Cooper S, Mantel C.
    Ann N Y Acad Sci; 2001 Jun 01; 938():117-27; discussion 127-8. PubMed ID: 11458498
    [Abstract] [Full Text] [Related]

  • 29. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE.
    Exp Hematol; 1993 Apr 01; 21(4):545-51. PubMed ID: 7681784
    [Abstract] [Full Text] [Related]

  • 30. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 31. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L, Xiao M, Li ZH, Jolliffe LK, Jones S, Broxmeyer HE, Weich N.
    Exp Hematol; 1995 Sep 01; 23(10):1130-4. PubMed ID: 7656932
    [Abstract] [Full Text] [Related]

  • 32. Opposing effects of PI3 kinase pathway activation on human myeloid and erythroid progenitor cell proliferation and differentiation in vitro.
    Lewis JL, Marley SB, Ojo M, Gordon MY.
    Exp Hematol; 2004 Jan 01; 32(1):36-44. PubMed ID: 14725899
    [Abstract] [Full Text] [Related]

  • 33. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A.
    J Immunol; 1991 Oct 15; 147(8):2586-94. PubMed ID: 1918979
    [Abstract] [Full Text] [Related]

  • 34. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
    Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S.
    Ann N Y Acad Sci; 2001 Jun 15; 938():36-45; discussion 45-7. PubMed ID: 11458524
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
    Goff JP, Shields DS, Petersen BE, Zajac VF, Michalopoulos GK, Greenberger JS.
    Stem Cells; 1996 Sep 15; 14(5):592-602. PubMed ID: 8888500
    [Abstract] [Full Text] [Related]

  • 38. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A, Yamaguchi N, Suda T.
    EMBO J; 1996 Nov 01; 15(21):5866-75. PubMed ID: 8918464
    [Abstract] [Full Text] [Related]

  • 39. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor.
    Banu N, Price DJ, London R, Deng B, Mark M, Godowski PJ, Avraham H.
    J Immunol; 1996 Apr 15; 156(8):2933-40. PubMed ID: 8609414
    [Abstract] [Full Text] [Related]

  • 40. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner.
    Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ.
    Blood; 2001 May 15; 97(10):3075-85. PubMed ID: 11342433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.